Back to Top

Indo global journal of pharmaceutical sciences (IGJPS)

Publisher :

iGlobal Research and Publishing Foundation

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • pharmaceutical sciences
  • pharmacy
  • Pharmacology
  • +2

e-ISSN :

2249-1023

Issue Frequency :

Quarterly

Est. Year :

2011

Mobile :

9818603719

DOI :

YES

Country :

India

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

editor@iglobaljournal.com

Journal Descriptions

IGJPS is an international journal online. It is interdisciplinary and aims to bring together different approaches for a diverse readership all over the world in pharmaceutical sciences. This Journal publishes original research work that contributes significantly to further the scientific knowledge in pharmacy and pharmaceutical sciences (Pharmaceutical Technology, Pharmacognosy, Natural Product Research, Pharmaceutics, Novel Drug Delivery, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest). The Journal publishes original research work either as a Full Research Paper or as a Short Communication. Review Articles on a current topic in the said fields are also considered for publication by the Journal.


Indo global journal of pharmaceutical sciences (IGJPS) is :

International, Peer-Reviewed, Open Access, Refereed, pharmaceutical sciences, pharmacy, Pharmacology, Toxicology, Pharmaceutics , Online Quarterly Journal

UGC Approved, ISSN Approved: P-ISSN , E-ISSN - 2249-1023, Established in - 2011, Impact Factor

Provide Crossref DOI

Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Publications of IGJPS

Research Article
  • dott image Tejal Soni
  • dott image April, 2023

Directly Compressible Sustained Release Matrix Tablets of Losartan Potassium via Crystallo-co-agglomeration

Background: Losartan potassium possesses poor bioavailability due to low elimination half-life and so requires to be developed as sustained release dosage form. Objectives: The present study...

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile